K

Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO

Watchlist Manager
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
Watchlist
Price: 69.83 INR -2.03% Market Closed
Market Cap: 1.5B INR

Operating Margin
Krebs Biochemicals and Industries Ltd

-79%
Current
-44%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-79%
=
Operating Profit
-215.1m
/
Revenue
272.2m

Operating Margin Across Competitors

No Stocks Found

Krebs Biochemicals and Industries Ltd
Glance View

Market Cap
1.5B INR
Industry
Pharmaceuticals

Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana. The firm manufactures various products, such as Androstenedione for use as Steroid Intermediate, and Lovastatin and Simvastatin for anti-cholesterol. The firm's products in either pilot or research and development stages include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. The firm has two manufacturing facilities one at Regadichelika, Nellore; and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam, Andhra Pradesh, India.

KREBSBIO Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-79%
=
Operating Profit
-215.1m
/
Revenue
272.2m
What is the Operating Margin of Krebs Biochemicals and Industries Ltd?

Based on Krebs Biochemicals and Industries Ltd's most recent financial statements, the company has Operating Margin of -79%.

Back to Top